Finally, we interrogated the pathways by which ALK/MEK inhibition suppressed cancer cell growth so as to identify more druggable targets, as the approach of Bozic et al. requires a combination of three drugs or more to maximise suppression of cancer cell growth and prevention of drug resistance. The gene discussed is MAP2K7; the disease is cancer.